ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Medicure Announces Appointment of David Gurvey as CFO
June 25, 2021Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF) is pleased to announce the appointment of Mr. David Gurvey (CPA, CMA, B.Sc.) as Chief Financial Officer, effective June 28, 2021. -
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
August 25, 2020Medicure Inc., a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT® (tirofiban hydrochloride) show promise for preventing and treating thrombotic complications due to COVID-19. -
M&As this week: Stallergenes Greer, Medicure, Eris Lifesciences
October 09, 2017UK-based biopharmaceutical company Stallergenes Greer has acquired Canadian allergy immunotherapy provider Medic Savoure.
Pharma Sources Insight January 2025
